日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

局部晚期直肠癌的新辅助治疗

Audisio, Alessandro; Gallio, Chiara; Velenik, Vaneja; Meillat, Hélène; Ruiz-Garcia, Erika; Riesco, Maria Carmen; Alecha, Javier Suárez; Rasschaert, Gertjan; Carvalho, Carlos; Randrian, Violaine; Kirac, Iva; Hernando, Jorge; Artaç, Mehmet; O'Connor, Juan Manuel; Waldhorn, Ithai; Braam, Pètra M; Shamseddine, Ali; Moretto, Roberto; De la Pinta, Carolina; De Felice, Francesca; Dulskas, Audrius; Páez López-Bravo, David; Vanden Bulcke, Alexander; Bock, Felix; Deleporte, Amélie; Van Den Eynde, Marc; Geboes, Karen P; Loi, Mauro; Messina, Marco; Houlzé-Laroye, Constance; Puccini, Alberto; Pastorino, Alessandro; Papamichael, Demetris; Fiore, Michele; Sur, Daniel; Eid, Michal; Antoun, Claire; Salati, Massimiliano; Garajovà, Ingrid; Jakubauskas, Matas; Tomášek, Jirí; Sousa Pinto, Cidália Maria; Schwingel, Jerome; Morano, Federica; Adams, Richard A; Dermine, Alexandre; Chau, Amélie; Javed, Muhammad Ahsan; Ghidini, Michele; Fiorica, Francesco; Montenegro, Paola; Petrillo, Angelica; Spolverato, Gaya; Mulet Margalef, Núria; Diaz, Marie; Baratelli, Chiara; Puleo, Francesco; Karampeazis, Athanasios; Sert, Fatma; Gilliaux, Quentin; De Stefano, Alfonso; Liberale, Gabriel; Moretti, Luigi; Martinive, Philippe; Deltuvaite Thomas, Vaiva; Staggs, Vincent; Saad, Everardo D; Van Laethem, Jean-Luc; Sclafani, Francesco

Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201)

retifanlimab治疗复发性局部晚期或转移性默克尔细胞癌患者的II期研究(POD1UM-201)

Grignani, Giovanni; Rutkowski, Piotr; Lebbé, Céleste; Guida, Michele; Gaudy-Marqueste, Caroline; Spagnolo, Francesco; Burgess, Melissa; Morano, Federica; Montaudié, Henri; Depenni, Roberta; Spada, Francesca; Yeung, Cecilia C S; Pulini, Jennifer; Cornfeld, Mark; Tian, Chuan; Bhatia, Shailender

The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib/IIa Trial

前列腺素EP4拮抗剂Vorbipiprant联合PD-1阻断治疗难治性微卫星稳定型转移性结直肠癌:一项Ib/IIa期试验

Pietrantonio, Filippo; Morano, Federica; Niger, Monica; Ghelardi, Filippo; Chiodoni, Claudia; Palazzo, Michele; Nichetti, Federico; Manca, Paolo; Cristarella, Eleonora; Doldi, Valentina; Zaffaroni, Nadia; Sabella, Giovanna; Brambilla, Nadia; Benincasa, Elena; Giacovelli, Giampaolo; Vitalini, Cristina; Girolami, Federica; Rovati, Lucio C

Spatial Heterogeneity, Stromal Phenotypes, and Therapeutic Vulnerabilities in Colorectal Cancer Peritoneal Metastasis.

结直肠癌腹膜转移的空间异质性、基质表型和治疗脆弱性

Ong Chin-Ann Johnny, Zhao Joseph J, Liu Ying, Srivastava Supriya, Chia Daryl K A, Quek Ying En, Fan Xiaonan, Ma Haoran, Huang Kie Kyon, Sheng Taotao, Tan Qiu Xuan, Ng Gillian, Tan Joey W S, Lee Jia-Ying Joey, Loo Lit-Hsin, Chong Li Yen, Ong Xue Wen, Tay Su Ting, Hagihara Takeshi, Tan Angie, Joseph Craig Ryan Cecil, Teo Melissa C C, Hendrikson Josephine, Chong Clara Y L, Guo Wanyu, Chia Claramae S, Wong Jolene S M, Seo Chin Jin, Cai Mingzhe, Tay Yvonne, Sim Kevin M S, Tay Ryan Y K, Walsh Robert, Guaglio Marcello, Morano Federica, Teh Ming, Lum Huey Yew Jeffrey, Lim Tony K H, Vermeulen Louis, Bijlsma Maarten F, Lenos Kristiaan, Klempner Samuel J, Yeong Joe P S, Yong Wei Peng, Pietrantonio Filippo, Tan Patrick, Sundar Raghav

Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trials

原发肿瘤侧别和负性超选择对RAS野生型转移性结直肠癌患者抗EGFR维持治疗策略的影响:两项随机临床试验的个体患者数据汇总分析

Ballhausen, Alexej; Morano, Federica; Stahler, Arndt; Lonardi, Sara; Kind, Andreas Jay; Cremolini, Chiara; Swoboda, Susanna; Randon, Giovanni; Horst, David; Prisciandaro, Michele; Alig, Annabel Helga Sophie; Pircher, Chiara Carlotta; Jarosch, Armin; Andena, Paola; Kurreck, Annika; Chiaramonte, Anna Alessandra; Stintzing, Sebastian; Pietrantonio, Filippo; Modest, Dominik Paul; Raimondi, Alessandra

Computational pathology applied to clinical colorectal cancer cohorts identifies immune and endothelial cell spatial patterns predictive of outcome

将计算病理学应用于临床结直肠癌队列,可识别预测预后的免疫细胞和内皮细胞空间分布模式。

Trahearn, Nicholas; Sakr, Chirine; Banerjee, Abhirup; Lee, Seung Hyun; Baker, Ann-Marie; Kocher, Hemant M; Angerilli, Valentina; Morano, Federica; Bergamo, Francesca; Maddalena, Giulia; Intini, Rossana; Cremolini, Chiara; Caravagna, Giulio; Graham, Trevor; Pietrantonio, Filippo; Lonardi, Sara; Fassan, Matteo; Sottoriva, Andrea

Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer patients: demystifying the 100% clinical complete response paradigm

dMMR/MSI-H局部晚期直肠癌患者的新辅助免疫疗法:揭开100%临床完全缓解范式的神秘面纱

Marmorino, Federica; Morano, Federica; Canciello, Maria Anna; Rossi, Piercarlo; Gandini, Annalice; Laurent-Puig, Pierre; Ugolini, Clara; Martinelli, Erika; Cremolini, Chiara

First-line maintenance strategies and later-line options in patients with advanced gastroesophageal adenocarcinoma

晚期胃食管腺癌患者的一线维持治疗策略和后续治疗选择

Marchesi, Silvia; Sciortino, Carolina; Etessami, Julian; Damonte, Camilla; Villa, Cecilia; Bottelli, Andrea; Alessandrini, Sara; Chiaramonte, Anna; Sabella, Giovanna; Pietrantonio, Filippo; Morano, Federica; Randon, Giovanni

Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: the multicentre, phase II randomized TRINITY trial

在接受术前化疗和根治性手术后液体活检仍存在微小残留病灶的HER2阳性胃癌或胃食管癌患者中,辅助性曲妥珠单抗德鲁替康联合氟尿嘧啶与标准化疗的疗效比较:一项多中心、II期随机TRINITY试验

Nasca, Vincenzo; Bergamo, Francesca; Foltran, Luisa; Antonuzzo, Lorenzo; Bencardino, Katia; Dell'Aquila, Emanuela; Corallo, Salvatore; Spallanzani, Andrea; Brunetti, Oronzo; Spada, Daniele; Tamberi, Stefano; Cella, Chiara Alessandra; Avallone, Antonio; Fornaro, Lorenzo; Di Donato, Samantha; Strippoli, Antonia; Puccini, Alberto; Tamburini, Emiliano; Palermo, Federica; Morano, Federica; Pietrantonio, Filippo; Raimondi, Alessandra

Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinoma

II期PANDORA试验的设计和原理:晚期默克尔细胞癌的一线化疗-免疫疗法

Oldani, Simone; Prinzi, Natalie; Morano, Federica; Cingarlini, Sara; Di Giacomo, Anna Maria; Niger, Monica; Prisciandaro, Michele; Raimondi, Alessandra; Randon, Giovanni; Pircher, Chiara Carlotta; Borghesani, Michele; Valente, Monica; Rostanzo, Elvira; Milione, Massimo; Sabella, Giovanna; Cascella, Tommaso; Ghelardi, Filippo; Sciortino, Carolina; Gusmaroli, Eleonora; Nasca, Vincenzo; de Braud, Filippo; Pietrantonio, Filippo; Pusceddu, Sara